199 related articles for article (PubMed ID: 19340910)
1. Guillain-Barré syndrome following hepatitis E.
Loly JP; Rikir E; Seivert M; Legros E; Defrance P; Belaiche J; Moonen G; Delwaide J
World J Gastroenterol; 2009 Apr; 15(13):1645-7. PubMed ID: 19340910
[TBL] [Abstract][Full Text] [Related]
2. Anti-glycolipid GM2-positive Guillain-Barre syndrome due to hepatitis E infection.
Cronin S; McNicholas R; Kavanagh E; Reid V; O'Rourke K
Ir J Med Sci; 2011 Mar; 180(1):255-7. PubMed ID: 21063804
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis E virus-associated Guillain-Barre syndrome: Revision of the literature.
Liu H; Ma Y
Brain Behav; 2020 Jan; 10(1):e01496. PubMed ID: 31828968
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
Ang CW; Jacobs BC; Brandenburg AH; Laman JD; van der Meché FG; Osterhaus AD; van Doorn PA
Neurology; 2000 Apr; 54(7):1453-8. PubMed ID: 10751257
[TBL] [Abstract][Full Text] [Related]
5. First case of anti-ganglioside GM1-positive Guillain-Barré syndrome due to hepatitis E virus infection.
Maurissen I; Jeurissen A; Strauven T; Sprengers D; De Schepper B
Infection; 2012 Jun; 40(3):323-6. PubMed ID: 21877179
[TBL] [Abstract][Full Text] [Related]
6. Anti-GM2 antibody positive Guillain-Barré syndrome presenting with ataxia in a pediatric patient: An atypical manifestation.
Deliceo Göbüt E; Us Ö; Işık U
Brain Dev; 2021 Jun; 43(6):729-733. PubMed ID: 33726944
[TBL] [Abstract][Full Text] [Related]
7. Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.
Kaida K; Ariga T; Yu RK
Glycobiology; 2009 Jul; 19(7):676-92. PubMed ID: 19240270
[TBL] [Abstract][Full Text] [Related]
8. Ganglioside mimicry as a cause of Guillain-Barré syndrome.
Komagamine T; Yuki N
CNS Neurol Disord Drug Targets; 2006 Aug; 5(4):391-400. PubMed ID: 16918391
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
Yuki N
Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
[TBL] [Abstract][Full Text] [Related]
10. CMV-associated axonal sensory-motor Guillain-Barré syndrome in a child: Case report and review of the literature.
Spagnoli C; Iodice A; Salerno GG; Frattini D; Bertani G; Pisani F; Fusco C
Eur J Paediatr Neurol; 2016 Jan; 20(1):168-75. PubMed ID: 26621312
[TBL] [Abstract][Full Text] [Related]
11. [Acute hepatitis E infection associated with Guillain-Barré syndrome in an immunocompetent patient].
Comont T; Bonnet D; Sigur N; Gerdelat A; Legrand-Abravanel F; Kamar N; Alric L
Rev Med Interne; 2014 May; 35(5):333-6. PubMed ID: 24080239
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination.
Hoshino T; Uchiyama Y; Ito E; Osawa S; Ohashi T
Intern Med; 2012; 51(12):1595-8. PubMed ID: 22728497
[TBL] [Abstract][Full Text] [Related]
13. [Guillain-Barré syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis].
Shimoya K; Ohnishi A; Hashimoto T; Yuki N
Rinsho Shinkeigaku; 1997 Feb; 37(2):106-10. PubMed ID: 9164140
[TBL] [Abstract][Full Text] [Related]
14. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection.
Khalili-Shirazi A; Gregson N; Gray I; Rees J; Winer J; Hughes R
J Neurol Neurosurg Psychiatry; 1999 Mar; 66(3):376-9. PubMed ID: 10084538
[TBL] [Abstract][Full Text] [Related]
15. Dysgeusia in a Patient with Guillain-Barré Syndrome Associated with Acute Hepatitis E: A Case Report and Literature Review.
Higuchi MA; Fukae J; Tsugawa J; Ouma S; Takahashi K; Mishiro S; Tsuboi Y
Intern Med; 2015; 54(12):1543-6. PubMed ID: 26073247
[TBL] [Abstract][Full Text] [Related]
16. Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
Ang CW; Endtz HP; Jacobs BC; Laman JD; de Klerk MA; van der Meché FG; van Doorn PA
J Neuroimmunol; 2000 May; 104(2):133-8. PubMed ID: 10713352
[TBL] [Abstract][Full Text] [Related]
17. Guillain-Barre syndrome caused by hepatitis E infection: case report and literature review.
Zheng X; Yu L; Xu Q; Gu S; Tang L
BMC Infect Dis; 2018 Jan; 18(1):50. PubMed ID: 29357816
[TBL] [Abstract][Full Text] [Related]
18. The Guillain-Barré syndrome: a true case of molecular mimicry.
Ang CW; Jacobs BC; Laman JD
Trends Immunol; 2004 Feb; 25(2):61-6. PubMed ID: 15102364
[TBL] [Abstract][Full Text] [Related]
19. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
[TBL] [Abstract][Full Text] [Related]
20. Progress in Guillain-Barré syndrome.
Hartung HP; Kieseier BC; Kiefer R
Curr Opin Neurol; 2001 Oct; 14(5):597-604. PubMed ID: 11562571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
